BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $209,000 | -9.9% | 2,700 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $232,000 | +6.9% | 2,700 | 0.0% | 0.02% | -4.2% |
| Q3 2021 | $217,000 | -3.6% | 2,700 | -3.6% | 0.02% | 0.0% |
| Q2 2021 | $225,000 | -4.7% | 2,800 | 0.0% | 0.02% | -14.3% |
| Q1 2021 | $236,000 | -96.7% | 2,800 | -96.8% | 0.03% | -97.0% |
| Q4 2020 | $7,052,000 | -7.6% | 87,888 | -7.4% | 0.93% | -13.1% |
| Q3 2020 | $7,634,000 | -5.3% | 94,926 | +1.3% | 1.07% | -13.9% |
| Q2 2020 | $8,065,000 | +5.9% | 93,671 | -0.1% | 1.24% | -15.8% |
| Q1 2020 | $7,614,000 | +3.1% | 93,781 | +6.2% | 1.47% | +21.1% |
| Q4 2019 | $7,382,000 | -2.3% | 88,276 | +2.2% | 1.22% | -12.5% |
| Q3 2019 | $7,554,000 | +6.2% | 86,361 | -0.5% | 1.39% | +3.0% |
| Q2 2019 | $7,110,000 | -4.2% | 86,816 | -4.9% | 1.35% | -4.3% |
| Q1 2019 | $7,421,000 | +24.4% | 91,266 | +0.7% | 1.41% | +6.3% |
| Q4 2018 | $5,967,000 | -16.4% | 90,654 | -2.1% | 1.33% | -1.8% |
| Q3 2018 | $7,140,000 | +5.9% | 92,619 | +1.4% | 1.35% | +0.4% |
| Q2 2018 | $6,744,000 | +15.1% | 91,344 | +1.4% | 1.34% | +12.5% |
| Q1 2018 | $5,859,000 | +5.0% | 90,079 | +4.3% | 1.20% | +6.1% |
| Q4 2017 | $5,581,000 | +0.7% | 86,335 | -2.2% | 1.13% | -1.2% |
| Q3 2017 | $5,541,000 | +4.0% | 88,295 | +0.3% | 1.14% | -0.6% |
| Q2 2017 | $5,328,000 | +15.5% | 87,990 | -1.0% | 1.15% | +11.8% |
| Q1 2017 | $4,611,000 | +16.4% | 88,910 | -0.4% | 1.03% | +7.2% |
| Q4 2016 | $3,960,000 | -7.1% | 89,300 | -0.2% | 0.96% | -8.7% |
| Q3 2016 | $4,261,000 | +562.7% | 89,520 | +529.1% | 1.05% | +551.6% |
| Q2 2016 | $643,000 | +2.1% | 14,230 | -7.2% | 0.16% | +9.5% |
| Q1 2016 | $630,000 | -1.3% | 15,335 | -8.3% | 0.15% | -6.4% |
| Q4 2015 | $638,000 | +13.5% | 16,720 | -2.3% | 0.16% | +6.1% |
| Q3 2015 | $562,000 | +17.3% | 17,120 | +149.9% | 0.15% | +27.6% |
| Q2 2015 | $479,000 | +59.7% | 6,850 | +67.1% | 0.12% | +61.1% |
| Q4 2014 | $300,000 | -93.4% | 4,100 | -94.1% | 0.07% | -93.5% |
| Q3 2013 | $4,547,000 | +1.4% | 69,220 | +6.9% | 1.11% | -6.4% |
| Q2 2013 | $4,485,000 | – | 64,749 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |